CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maskarinec, G.
Right arrow Articles by Franke, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maskarinec, G.
Right arrow Articles by Franke, A. A.
Cancer Epidemiology Biomarkers & Prevention Vol. 11, 195-201, February 2002
© 2002 American Association for Cancer Research

A Randomized Isoflavone Intervention among Premenopausal Women1

Gertraud Maskarinec2, Andrew E. Williams, Judith S. Inouye, Frank Z. Stanczyk and Adrian A. Franke

Cancer Research Center of Hawaii, Honolulu, Hawaii 96813 [G. M., A. E. W., J. S. I., A. A. F.], and University of Southern California, Los Angeles, California 90033 [F. Z. S.]

Isoflavones, phytoestrogens contained in soy foods, may play a role in breast cancer prevention. This randomized double-blinded trial with 34 premenopausal women investigated whether 100 mg of isoflavones per day versus placebo affects the ovulatory cycle during 1 year. Compliance with the study regimen was confirmed by the increase of urinary isoflavone excretion among the intervention group. Blood samples were taken 5 days after ovulation as determined by an ovulation kit, at baseline, and at months 1, 3, 6, and 12. Serum levels of estrone, estradiol, estrone sulfate, progesterone, sex hormone-binding globulin, follicle-stimulating hormone, and luteinizing hormone were quantified by immunoassay; free estradiol was calculated. We applied the method of least squares to fit general linear models to test for an intervention effect while taking into account the repeated measurement design. Except for a small difference in age, the two groups were comparable at baseline. Menstrual cycle length did not change significantly during the intervention [F(1,32) = 0.69; P = 0.44]. During 1 year, we did not observe any significant changes in hormone levels by treatment group. The difference in change between intervention and control group was -13.0 pg/ml (95% confidence interval, -57.5 to 31.5) for estradiol and 6.9 pg/ml (95% confidence interval, -17.8 to 31.5) for estrone. Exclusion of 22 non-ovulatory cycles, noncompliant women, or non-Asian women did not affect the results. These findings do not support the hypothesis that isoflavones affect the ovulatory cycles of premenopausal women over a 1-year period. However, isoflavones alone may have different effects on the reproductive cycle than isoflavones present in soy foods.




This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
D. Caserta, L. Maranghi, A. Mantovani, R. Marci, F. Maranghi, and M. Moscarini
Impact of endocrine disruptor chemicals in gynaecology
Hum. Reprod. Update, January 1, 2008; 14(1): 59 - 72.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
C. Duffy, K. Perez, and A. Partridge
Implications of Phytoestrogen Intake for Breast Cancer
CA Cancer J Clin, September 1, 2007; 57(5): 260 - 277.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. Messina, W. McCaskill-Stevens, and J. W. Lampe
Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings.
J Natl Cancer Inst, September 20, 2006; 98(18): 1275 - 1284.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
C. Atkinson, C. L. Frankenfeld, and J. W. Lampe
Gut Bacterial Metabolism of the Soy Isoflavone Daidzein: Exploring the Relevance to Human Health
Experimental Biology and Medicine, March 1, 2005; 230(3): 155 - 170.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. Maskarinec, A. A. Franke, A. E. Williams, S. Hebshi, C. Oshiro, S. Murphy, and F. Z. Stanczyk
Effects of a 2-Year Randomized Soy Intervention on Sex Hormone Levels in Premenopausal Women
Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1736 - 1744.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. E. Wood, J. M. Cline, M. S. Anthony, T. C. Register, and J. R. Kaplan
Adrenocortical Effects of Oral Estrogens and Soy Isoflavones in Female Monkeys
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2319 - 2325.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. D Brooks, W. E Ward, J. E Lewis, J. Hilditch, L. Nickell, E. Wong, and L. U Thompson
Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy
Am. J. Clinical Nutrition, February 1, 2004; 79(2): 318 - 325.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2002 by the American Association for Cancer Research.